Don't miss any news, subscribe to our press releases.
Sprint Bioscience has been listed on Nasdaq First North Premier Growth Market since 2014. The company's shares are traded under the ticker symbol SPRINT. Here we have collected all financial information about the company.
Johan Emilsson, CEO, Sprint Bioscience
Telephone: 08-411 44 55
E-mail: johan.emilsson@sprintbioscience.com